US Patent Issued to Ludwig Institute for Cancer Research, Ecole Polytechnique Federale de Lausanne on Jan. 20 for "Heterodimeric inactivatable chimeric antigen receptors" (Swiss Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,847, issued on Jan. 20, was assigned to Ludwig Institute for Cancer Research Ltd ((), Switzerland) and Ecole Polytechnique Federale de Lausanne (Lausanne, Switzerland).

"Heterodimeric inactivatable chimeric antigen receptors" was invented by George Coukos (Epalinges, Switzerland), Melita Irving (Epalinges, Switzerland), Bruno Correia (Lausanne, Switzerland), Pablo Gainza-Cirauqui (Lausanne, Switzerland) and Greta Maria Paola Giordano Attianese (Lausanne, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to heterodimeric inactivatable chimeric antigen receptors (CARs) and their use for treatment."

The patent was filed ...